The therapeutic potential of neural stem/progenitor cells in murine globoid cell leukodystrophy is conditioned by macrophage/microglia activation

Neurobiol Dis. 2006 Feb;21(2):314-23. doi: 10.1016/j.nbd.2005.07.016. Epub 2005 Sep 30.

Abstract

Twitcher (GALC(twi/twi)) is the murine model of globoid cell leukodystrophy (GLD or Krabbe disease), a disease caused by mutations of the lysosomal enzyme galactocerebrosidase (GALC). To verify the therapeutic potential on twitcher of neural stem/progenitor cells (NSPC), we transduced them with a GALC lentiviral vector. Brain injection of NSPC-GALC increased survival of GALC(twi/twi) from 36.1 +/- 4.1 to 52.2 +/- 5.6 days (P < 0.0001). Detection of GALC activity and flow cytometry showed that NSPC-GALC and NSPC expressing the green fluorescent protein were attracted to the posterior area of twitcher brain, where demyelination occurs first. GALC(twi/twi) microglia, also more abundant in posterior regions of the brain, released significant amounts of the cytotoxic cytokine TNF-alpha when matched with NSPC-GALC. Thus, in murine GLD, and possibly in other demyelinating diseases, NSPC are attracted to regions of active demyelination but have limited survival and therapeutic potential if attacked by activated macrophages/microglia.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Disease Models, Animal
  • Flow Cytometry
  • Galactosylceramidase / genetics
  • Galactosylceramidase / metabolism
  • Gene Transfer Techniques
  • Genetic Therapy / methods
  • Leukodystrophy, Globoid Cell / therapy*
  • Macrophage Activation / physiology*
  • Macrophages / metabolism*
  • Mice
  • Microglia / metabolism*
  • Neurons / cytology
  • Neurons / transplantation*
  • Stem Cell Transplantation*
  • Transduction, Genetic

Substances

  • Galactosylceramidase

Grants and funding